Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Mechanisms Within the Autonomic Nervous SysTEm undeRlying MusIc Therapy's aNalgesic Effects in Sickle Cell Disease (MASTERMIND)

4. november 2026 oppdatert av: Kamal Chemali, University Hospitals Cleveland Medical Center

Sickle cell disease causes very painful episodes that can happen without warning. Pain is one of the biggest problems for people with SCD. Medicines like opioids can help, but they have serious side effects. Doctors are looking for other ways to treat pain.

Investigators have already found that music therapy - breathing exercises guided by a trained music therapist - can lower pain in adults with SCD. But investigators don't know exactly how it works yet inside the body.

This study will look at two possible reasons why music therapy helps:

  • It may calm the body's "fight-or-flight" (sympathetic) nervous system, which can make pain worse when it is too active.
  • It may boost the "calming" (parasympathetic) nervous system, which may ease pain and reduce inflammation.
  • It may lower swelling and inflammation in the body, which also drives pain.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

10

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • (1) are age ≥18 years
  • (2) have a diagnosis of SCD documented in the electronic health record (EHR)--- (3) meet Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society Pain Taxonomy (AAPT) criteria for chronic SCD pain
  • (4) are able to speak and understand English
  • (5) have an email address and access to a mobile device with a functioning data plan (to get pain diaries)
  • (6) report that pain interfered with daily activities at least 1-2 days in past week will be eligible for the study. -

Exclusion Criteria:

  • (1) have < 3 vaso-occlusive crises (VOCs) per year and no VOCs in the past 3 months
  • (2) have significant visual, hearing, psychiatric or cognitive impairment
  • (3) are currently engaged in mind-body therapies under the supervision of a healthcare professional specifically for pain management
  • (4) have a planned major medical event in next 8 weeks (e.g., childbirth, orthopedic surgery, gene therapy, stem cell transplant) that does not include routine disease modifying therapies (e.g., blood transfusions)
  • (5) are unable or unwilling to refrain from stopping all medications that interfere with the autonomic nervous system for 5 half-lives prior to autonomic testing and from changing their medication regimen during the 2 weeks that separate autonomic testings and blood draws
  • (6) develop active VOC requiring hospitalization at enrollment
  • (7) have conditions that would significantly affect autonomic testing interpretation, such as severe arrhythmias or pregnancy, will be excluded from the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Music Therapy

The MT-BC will engage the participant in a 20-minute deep breathing exercise with live music beating at a defined tempo. Participants will repeat this session on their own.

Participants will undergo a 20-minute music therapy session with a board certified music therapist, then will repeat this on their own once daily for 2 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in electrodermal activity (EDA) as measured by change in electrical potential at the surface of the skin
Tidsramme: Baseline and after 2 weeks

Lower EDA reflects less sympathetic tone

Baseline and after 2 weeks
Change in Quantitative Sudomotor Axon Reflex Test (QSART) as measured by sweat output values
Tidsramme: Baseline and after 2 weeks

Lower QSART values reflect less sympathetic activity

Baseline and after 2 weeks
Changes in Pupillometry parameters as measured by constriction velocity
Tidsramme: Baseline and after 2 weeks

Faster constriction velocity indicates a higher pupillary vagal tone.

Baseline and after 2 weeks
Changes in Pupillometry parameters as measured by percent reflex amplitude
Tidsramme: Baseline and after 2 weeks

Larger percentage of reflex amplitude indicates higher pupillary vagal tone.

Baseline and after 2 weeks
Changes in Pupillometry parameters as measured by dilation velocity.
Tidsramme: Baseline and after 2 weeks.

Slower dilation velocity indicates lower pupillary sympathetic tone.

Baseline and after 2 weeks.
Change in Heart Rate Response to deep breathing
Tidsramme: Baseline and after 2 weeks

Increased heart rate response to deep breathing denotes increased cardiovagal tone.

Baseline and after 2 weeks
Measurement of average supine resting Blood Pressure (BP)
Tidsramme: Baseline and after 2 weeks

Lower average resting BP denote lower cardiac sympathetic tone

Baseline and after 2 weeks
Measurement of average supine resting Heart Rate (HR)
Tidsramme: Baseline and after 2 weeks

Lower average resting HR denote lower cardiac sympathetic tone

Baseline and after 2 weeks
Change in supine resting respiratory rate
Tidsramme: Baseline and after 2 weeks

A lower resting respiratory rate reflects a shift of autonomic balance toward parasympathetic (vagal) dominance with reduced central sympathetic outflow.

Baseline and after 2 weeks
Change in the maximum heart rate during the Valsalva maneuver
Tidsramme: Baseline and after 2 weeks

An increased Valsalva Ratio (maximum heart rate to the minimum heart rate) reflects an increase in cardiac parasympathetic tone.

Baseline and after 2 weeks
Change in the minimum heart rate shortly after the Valsalva maneuver
Tidsramme: Baseline and after 2 weeks

An increased Valsalva Ratio (maximum heart rate to the minimum heart rate) reflects an increase in cardiac parasympathetic tone.

Baseline and after 2 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in C Reactive Protein as measured by bloodwork
Tidsramme: Baseline and after 2 weeks

Lower levels of CRP indicate lower levels of inflammation

Baseline and after 2 weeks
Change in Cytokine levels as measured by bloodwork
Tidsramme: Baseline and after 2 weeks

Lower levels of cytokines indicate lower levels of inflammation

Baseline and after 2 weeks

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain intensity changes as measured by the Visual Analog Scale (VAS)
Tidsramme: Baseline and after 2 weeks of daily music therapy

The VAS is a straight 100 mm line-usually horizontal-with descriptive word anchors at each end representing opposite extremes of a subjective experience, such as 0 being "no pain" and 10 being "worst possible pain".

Baseline and after 2 weeks of daily music therapy
Pain intensity changes as measured by the Brief Pain Inventory (BPI)
Tidsramme: Baseline and after 2 weeks of daily music therapy

Brief Pain Inventory (BPI) is a self-administered questionnaire used to evaluate pain severity and how pain interferes with daily life on scales from 0 to 10, with 0 being no pain, and 10 being severe pain.

Baseline and after 2 weeks of daily music therapy
Pain diaries
Tidsramme: Daily for 2 weeks

Daily pain intensity and analgesic use

Daily for 2 weeks
Music therapy adherence
Tidsramme: Daily for 2 weeks

Daily log of adherence to the home-based music therapy protocol

Daily for 2 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Kamal R Chémali, MD, University Hospitals

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

2. januar 2027

Primær fullføring (Antatt)

30. juni 2028

Studiet fullført (Antatt)

30. juni 2028

Datoer for studieregistrering

Først innsendt

14. oktober 2026

Først innsendt som oppfylte QC-kriteriene

4. november 2026

Først lagt ut (Faktiske)

10. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere